SBIR grants are no longer the program founders read about in 2024. After a six-month lapse that froze new solicitations across every participating agency, the Small Business Innovation and Economic Security Act (S. 3971) was signed into law on April 13, 2026, reauthorizing both SBIR and STTR through September 30, 2031 and rewriting several of the rules founders plan around. According to the NIH policy notice published April 20, 2026, agencies are now operating under a different statutory framework — and the implementing guidance still landing this quarter changes what a competitive proposal looks like.

The 195-Day Lapse Reset Every SBIR Pipeline

From October 1, 2025 through April 13, 2026, federal agencies could not issue new SBIR or STTR solicitations or obligate new awards. That is a fact, not a forecast — the prior statutory authorization expired on September 30, 2025, and Congress did not extend it before then. Industry analyses put the gap at 195 days, the longest pause in the program’s 43-year history.

That gap matters for two reasons. First, every roadmap pre-dating October 2025 assumed continuous solicitations; founders who timed Phase I submissions to a Q1 2026 close did not have a Q1 2026 close. Second, the lapse created a backlog of selections that agencies had identified but could not award. The reauthorization explicitly authorizes agencies to clear that backlog on an expedited basis — meaning some firms now in late-stage evaluation may see SBIR grants land faster than under normal cycles, while firms newly entering the funnel face a crowded queue.

For founders evaluating SBIR grants as a non-dilutive capital source, the practical takeaway is simple: any advice published before September 30, 2025 about timing, cycle cadence, or agency posture should be treated as expired until corroborated against a post-April 13, 2026 source. The OpenGrants SBIR/STTR hub is being refreshed against the new statute as agency guidance posts; treat hub pages as the canonical timeline for now.

Strategic Breakthrough Phase II Is the Real Headline

The most consequential addition in the 2026 reauthorization is a new post-Phase II funding category called Strategic Breakthrough. Under the traditional structure, Phase II awards have settled around $2 million over 24 months, with a gap — the well-documented “valley of death” — between Phase II completion and Phase III commercialization revenue. Strategic Breakthrough is designed to close that gap with awards of up to $30 million over 48 months, paired with 100% matching funds from private capital or non-SBIR government sources.

The eligibility filter is tight by design. Per the legal summary published by Fox Rothschild on April 21, 2026, Strategic Breakthrough authority is restricted to agencies with annual SBIR obligations exceeding $100 million. That set is short — DoD, NIH, DOE, NASA, and NSF — and each agency’s allocation is capped at 0.5% of its overall extramural R&D budget. The Department of Defense and HHS together accounted for roughly 80% of FY2022 SBIR obligations, so they will dominate Strategic Breakthrough volume.

For founders, the practical question is whether to position now for a Strategic Breakthrough award later. The honest answer for most companies in Phase I or early Phase II in May 2026 is no — the SBA implementing guidance is still being drafted, agencies will only update solicitations to reflect the new category over the FY2026 and FY2027 cycles, and the first awards are most likely in late FY2026 or FY2027. The companies that will land the earliest Strategic Breakthrough awards are firms already performing on a Phase II with a clear transition partner and category-defining technology. Everyone else should keep building the Phase I or Phase II story that earns the right to apply.

What Strategic Breakthrough Does Not Change

The Phase I ceiling is unchanged. The standard Phase II ceiling is unchanged. The 3.2% SBIR agency set-aside and 0.45% STTR set-aside are unchanged. Strategic Breakthrough sits above the standard Phase II ceiling — it does not replace it. If you have a Phase I plan that worked in early 2025, the math still works in 2026.

Per-Firm Proposal Caps Begin in FY2027

The reauthorization tightens how many SBIR proposals a single firm can submit. Beginning FY2027, every participating agency must establish a per-firm submission limit using one of three frameworks: a fiscal-year basis, a per-solicitation basis, or a per-topic basis. Agencies have 90 days after the start of FY2027 to publish their chosen framework. Waivers exist for time-sensitive or urgent technology needs but are capped at 5% of topics in any fiscal year, with notice to the SBA Administrator and Congress within 30 days.

The target of this provision is the small group of firms — the NSBA Small Business Technology Council’s May 6, 2026 analysis describes them as the largest and most frequent applicants — that have built businesses around submitting hundreds of SBIR proposals per year across agencies. For the typical small business submitting two to ten proposals annually, the cap is unlikely to bind. For firms in or near the top quartile of applicants, the structure of the funnel will change, and diversification across more agencies or topics will become a deliberate strategy rather than a tactical preference.

One detail to plan around: the proposal cap is selected at the agency level. The agency that runs SBIR in your sector may pick a per-topic cap, while a sister agency picks a per-fiscal-year cap. Read each agency’s FY2027 implementation memo before submitting. Founders looking for a one-stop view of solicitations across agencies can use the OpenGrants federal grant database to filter by deadline and topic.

The FY2026 Carryover Is the Sleeper Provision

Buried in the reauthorization is a clause that lets agencies roll over unspent FY2026 SBIR and STTR funds into FY2027. That is not a small accounting detail. During the 195-day lapse, agencies could not obligate award funds even though appropriations were sitting in accounts. Without the rollover, that money would have evaporated at the end of the fiscal year. With it, the addressable pool for new awards in FY2027 is meaningfully larger than appropriations alone would imply.

How much larger? The exact figure is not yet public — it depends on what each agency had pre-obligated against selections made before the lapse and how much SBA implementing guidance directs into the new Strategic Breakthrough category versus standard Phase I and Phase II. The SBIR.gov awards database shows the program obligates roughly $4 billion in SBIR and another $600 million in STTR annually in recent years. Even a 20% rollover rate would mean an extra $800 million-plus competing for selection in FY2027.

For founders, the takeaway is that FY2027 is likely to be one of the most active SBIR cycles in recent memory. Two windows matter: the late FY2026 backlog-clearing window (now through September 30, 2026), and the FY2027 push starting October 1, 2026. Companies that have a Phase I narrative ready for May or June 2026 solicitations are positioned for the first window; companies still in research mode should target FY2027 and use the intervening months to harden their commercialization plan. Founders new to federal R&D funding can study what winning narratives look like at the small business grants hub.

Foreign Risk Due Diligence Just Got Real

The reauthorization significantly expands the national security and foreign-ownership screening that agencies must perform before issuing SBIR awards. Per the NIH policy notice cited above, agencies are now required to deny awards to small businesses with connections to entities on the Section 889 Prohibition List, the Military End User List, the 1260H list of Chinese military companies, and the Non-SDN Chinese Military Industrial Complex Companies List. A broad catch-all authority lets agencies deny any award where the applicant “has a security risk that the Federal agency determines warrants a denial.”

For most small businesses with U.S. ownership, supply chains, and key personnel, this is a paperwork change rather than a substantive obstacle. For companies with international co-founders, foreign investors, or supply relationships overseas, the diligence cost just went up materially. Plan a clean disclosure package before submitting — and budget for legal review of any equity structures involving foreign country relationships. Recipients are also now required to file updated disclosure forms within 30 days of any change in ownership or entity structure during the life of an award, with annual updates at each Research Performance Progress Report. Failing to comply can require repayment of award funds.

The 90-Day Action Plan for Founders

Between now and August 2026, here is the sequence that gets the most leverage out of the new statute. First, audit any in-flight Phase I or Phase II proposal against the new foreign-risk diligence requirements. Tighten ownership disclosures and prepare the supporting documentation before agency requests arrive. Second, watch the DoD SBIR 26.1 solicitation that opened the same day S. 3971 was signed — 115 topics dropped on April 13, 2026, with typical close dates in June. Third, position any post-Phase II conversation around transition partners and matching capital. Strategic Breakthrough awards are not for everyone, but the agencies that will run them are looking for narrative right now. Fourth, monitor SBA implementing guidance, expected May through June 2026, for the per-firm cap framework. Diversify your topic and agency mix before the cap forces it on you.

If you do not yet have a grant writer or capture team set up for federal R&D, the months before FY2027 are the right time to build that bench. OpenGrants’ managed grant writing services can match firms to writers with prior SBIR Phase I and Phase II wins.

Frequently Asked Questions

Did the Phase I or Phase II dollar ceilings change in 2026?

No. The standard Phase I ceiling and standard Phase II ceiling are unchanged. What is new is a separate category called Strategic Breakthrough Phase II, which sits above the standard Phase II ceiling and is authorized at up to $30 million over 48 months for agencies with annual SBIR obligations above $100 million. Strategic Breakthrough requires 100% matching funds from private capital or non-SBIR government sources and is being phased in through SBA implementing guidance over FY2026 and FY2027.

When do per-firm SBIR proposal caps take effect?

Caps begin in FY2027, which starts October 1, 2026. Each participating agency has 90 days after the start of FY2027 to publish its chosen framework — a fiscal-year cap, a per-solicitation cap, or a per-topic cap. Until then, FY2026 follows the prior rules. Waivers are available for up to 5% of an agency’s topics in any year, with written justification to the agency Undersecretary and the SBA Administrator.

Will my FY2026 SBIR application still be evaluated?

Yes, and possibly faster than expected. The reauthorization explicitly authorizes agencies to clear the backlog of selections identified during the lapse on an expedited basis. If you submitted before September 30, 2025 and were in evaluation when authority lapsed, agencies now have the authority to award. Track communication from the contracting officer at the agency you submitted to and confirm that the FY2026 funding rollover applies to your selection.

How does this affect STTR grants specifically?

STTR was reauthorized on the same timeline and to the same 2031 sunset. The 0.45% STTR set-aside is unchanged, as is the requirement that STTR projects include a research institution partner. STTR firms are eligible for the same Strategic Breakthrough category if their lead agency exceeds the $100 million annual SBIR threshold. The foreign-risk diligence and proposal-cap changes apply identically to STTR.

Bottom Line: Treat 2026 SBIR as a New Game, Not an Upgrade

The fundamentals of the program — non-dilutive capital, federal R&D priorities, the Phase I to Phase II to Phase III progression — are intact. The mechanics around timing, ownership disclosure, post-Phase II scale, and proposal volume are not. Founders who treat 2026 SBIR grants like a continuation of 2024 SBIR grants will miss the new Strategic Breakthrough lane, get caught off-guard by the foreign-risk reviews, and walk into the FY2027 proposal caps without a diversified topic strategy. Founders who recalibrate now will be on the first wave of awards when FY2027 opens.

The specific recommendation: pick one of the next 60 days to read the SBA implementing guidance the day it drops, redraft any in-flight foreign-ownership disclosures against the new statutory criteria, and put one Strategic Breakthrough conversation on your roadmap for late FY2026 if you have a Phase II transition story. If you want help mapping current opportunities to your stage, browse the OpenGrants funding database for live SBIR and STTR solicitations across all participating agencies.